The neuropeptide somatostatin (SST) is an important modulator of neurotransmission in the central nervous system (CNS) and binds to G-protein-coupled receptors (SSTR1-5) on target cells. Little is known about the expression and function of the somatostatinergic system in the mammalian cochlea. We analyzed the expression of SSTR1-SSTR5 in the immature mammalian cochlea. The peak in the expression of SSTR1 and SSTR2 at mRNA and protein level is around the onset of hearing to airborne sound, at postnatal day (P)14. This suggests their involvement in the maturation of the mammalian cochlea. We demonstrated that all five receptors are expressed in the inner hair cells (IHC) and outer hear cells (OHC) as well as in defined supporting cells of the organ of Corti (OC) in the adult mouse cochlea. A similar expression of the SSTRs in the IHC and OHC was found in cultivated P6 mouse OC explants as well as in neuroepithelial cell culture. In order to learn more about the regulation of SSTRs, we used mice with either a deletion of SSTR1, SSTR2 or SSTR1/SSTR2 double knock out (DKO). In DKO mice, SSTR5 was up-regulated and SSTR3 and SSTR4 were down regulated. These findings provide evidence of a compensatory regulation in the mammalian cochlea as a consequence of a receptor subtype deletion. In addition, we observed reduced levels of phospho-Akt and total-Akt in SSTR1 KO and DKO mice as compared to wild type (WT) mice. Akt is likely to be involved in hair cell survival. Most importantly, we found improved hair cell survival in somatostatin and octreotide treated OC explants that had been exposed to gentamicin compared to those explants exposed to gentamicin alone. These findings propose that the somatostatinergic system within the cochlea may have neuroprotective properties.
Also, SST-like immunostaining could be observed in the cochlear nuclei of postnatal rats and it was suggested that somatostatin might be important for the development of the auditory system [15] . In an additional study, SST producing cells could be observed in the covering epithelium of the spiral prominence and in the epithelium of the intermediate and rugosal part of the endolymphatic sac [16] .
In recent studies from our group, we demonstrated expression of SSTR1 and SSTR2 mRNA in the postnatal rat cochlea and we reported on a dose-dependent protective effect of somatostatin on gentamicin-induced HC loss in vitro [17] .
The present review will focus on the relevant aspects of SSTRs expression during development and in the mature mouse cochlea. In addition, it provides information concerning recent and unpublished data from our laboratory, in particular focusing on recent studies using cochlea of mice carrying genetic deletion of the SSTR1, SSTR2 and deletion of both SSTR1 and SSTR2 as experimental models. Finally, the evidence will be reviewed supporting a possible role of SST in maturation of the cochlea and for the hearing process.
Somatostatin and localization of somatostatin receptors in the mammalian cochlea
Many studies suggested that all SSTRs types are widespread throughout the brain and are variably expressed in the brain. In the rat, [18] . The distribution of the mRNA expression for all five SSTRs types has been investigated extensively using different technique in the rat and human [19] . At present, very little is known Transient expression of SST protein or mRNA has been described in the cerebellum [22] , the cerebral cortex [23] , and in sensory systems, including the somatosensory, visual [24] , and auditory systems [25] . Recent studies have shown that SST exerts some regulatory effects during neuronal maturation, as it has been reported that SST enhances neurite outgrowth in cultured cerebellar neurons [26] . In the postnatal period of cochlear development the immunostaining of both receptors increases until approximately P14 at the onset of hearing.
During this postnatal period maximal labeling of the IHC, OHC, and supporting cells is reached for both receptors, and subsequently decreases by P21 [20] . SST is also known to modify the synapses and is likely to influence the synaptic activity of the inner ear at P14 [27] .
Like other rodent species, mice do not respond to airborne sound shortly after birth. The outer ear canal remains closed until P12, and auditory brainstem responses cannot be reliably recorded before P12-P14 [28] . The increase of these proteins until P14 may be necessary for the growth and development of the OC, although not for mature hearing. In addition, it is noteworthy that the developmental pattern Figure 2D ) [30] . Somatostatin itself was not expressed in the mammalian cochlea, suggesting that somatostatin reaches its receptors either through the blood-labyrinthine barrier from the systemic circulation or via the endolymphatic duct from the endolymphatic sac [30] .
Expression of somatostatin receptors in cochlea of knock out mice
The KO and DKO mice in which SSTR1 and SSTR2 are knocked out have been generated and used to investigate the biological consequences of the absence of SSTRs [35] . These KO and DKO do not exhibit major phenotypic defects or main behavioral impairments [36] .
Immunohistochemisty in SSTR1 KO cochlea shows that SSTR2 was increased in SSTR1 KO mice. SSTR2 protein was strongly expressed in DeC, and to a lesser extent in OHC, but was absent from PiC and IHC compared with WT mice. In SSTR2 KO the staining pattern did not differ from that of WT mice [30] . In addition, no major compensatory regulation of SST or individual SSTRs has been described as a consequence of the genetic deletion of SSTR1 or SSTR2 in specific brain regions [37] . In the retina, recently major alterations of SST content were demonstrated as a consequence of SSTR1 or SSTR2 deletion [38] . Indeed, SSTR1 loss causes an increased expression of SSTR2 [30] . In the DKO mouse cochlea the expression of SSTR3 mRNA, as measured with quantitative qPCR in OC explants from P21 day-old mice was not significantly changed but the expression of SSTR4 in OC explants from P21 day-old mice was significantly decreased compared to age matched OC explants from WT mice. SSTR5
mRNA was expressed at a significantly higher level compared to WT cochlea (Figure 4 ). [39] . Activation of the SSTR2 by somatostatin or its analogues has been shown to protect retinal neurons against ischemia-induced damage [7] . In addition, studies in mice with genetic alterations of the somatostatinergic system have revealed that an increased presence of functional SSTR2 protects against retinal ischemia. Therefore, SSTR2 analogues might be of therapeutic benefit in retinal diseases such as glaucoma or diabetic retinopathy, but may also protect from hearing loss due to HC degeneration and death. Studies in mouse retinal explants have demonstrated that the SSTR2 receptor inhibits potassium-induced glutamate release [40] . By limiting the amount of glutamate available to glutamate receptors, somatostatin and its analogues may exert a neuroprotective function against glutamate neurotoxicity, which characterizes many retinal diseases [41] .
Role
Glutamate excitotoxicity appears to be mediated by the activation of caspase-3, as shown in cortical neurons [42] . Glutamate excitotoxicity is also involved in HC damage and death in the cochlea [43] . Therefore, somatostatin may protect HCs from aminoglycoside toxicity, either by limiting glutamate release or by mitigating the toxic action of excess glutamate on HCs. In this context, it is notable that the somatostatin analogue octreotide alters the activity of the phosphatidylinositol 3-kinase pathway in pituitary tumor cells [44] . We demonstrated recently that the phosphatidylinositol 3-kinase pathway is involved in NF-kappaB-dependent HC survival [45] . Therefore, it might be possible that somatostatin exerts its effect on HCs through the phosphatidylinositol 3-kinase survival pathway. Our analysis of levels of phospho-Akt and total Akt protein in WT, SSTR1 KO, and DKO mice demonstrated that deletion of the receptors results in reduced levels of phospho-Akt and total Akt in the KO mice compared with WT mice ( Figure 5B ) [20] .
Therefore, we can speculate that the protective role of SST on gentamicin-induced HC loss is due to the influence of SST at the PI3K/Akt pathway. 
